Tennessee Senate Bill SB1786

Tennessee 2023-2024 Regular Session

• Introduced: 1/22/24

Caption

AN ACT to amend Tennessee Code Annotated, Title 43; Title 53 and Title 68, relative to products containing perfluoroalkyl and polyfluoroalkyl.

Impact

The implications of SB1786 are considerable, as it establishes new restrictions on the use of PFASs across multiple product categories in Tennessee. By limiting the presence of these chemicals, which have been linked to adverse health effects, the bill aims to promote safer consumer products and enhance environmental protection. The bill empowers the commissioner of environment and conservation to enforce these laws and develop regulations accordingly. While the bill will take effect in 2025 for most provisions, it aims to proactively phase out harmful substances from everyday items.

Summary

SB1786, an act proposed to amend the Tennessee Code, addresses the regulation of products containing perfluoroalkyl and polyfluoroalkyl substances (PFAS). The bill prohibits the manufacture, sale, or distribution of products that contain intentionally added PFASs, aiming to mitigate the public health risks associated with these chemicals. The legislation places significant emphasis on food packaging and a variety of consumer products such as cleaning supplies, textiles, and children's items, prohibiting the use of PFASs in these areas unless exceptions apply.

Sentiment

The prevailing sentiment surrounding SB1786 appears to be supportive among environmental advocacy groups and public health officials who recognize the pressing need to address the hazards posed by PFASs. While proponents laud the effort to protect consumers and the environment, there are concerns from affected industries regarding the feasibility of finding suitable alternatives and the potential economic impact of such regulations. This reflects a broader tension between health and safety priorities and the economic realities of manufacturing and product development.

Contention

Notable points of contention include concerns from manufacturers about the bill's impact on certain industries that rely on PFASs for product stability and performance. The exceptions outlined in the bill, which include certain medical devices and the use of PFASs within specific high-risk environments such as airports and oil refineries, are also critical talking points. Critics may argue that the timeline for enforcement could generate uncertainty regarding compliance and the future of certain product lines, leading to a contentious debate on how to balance health, safety, and economic viability in implementation.